Literature DB >> 2021545

Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features.

L Pedersen1, K Zedeler, S Holck, T Schiødt, H T Mouridsen.   

Abstract

In a previous study of 131 breast carcinomas with medullary features, we evaluated the diagnostic inter- and intraobserver variation and its prognostic implications using the criteria of typical (TMC) and atypical (AMC) medullary carcinoma of the breast put forward by Ridolfi et al. (1977). We found a considerable interobserver variation as well as intraobserver variation, with significant implication on prognosis, and concluded that the histopathological definition of MC must be sharpened and simplified in order to increase the diagnostic reproducibility. In the present study of the same population of 131 patients with breast carcinomas with medullary features we have examined inter- and intraobserver variation concerning 11 histopathological characteristics. Furthermore, we have analysed the prognostic importance of these 11 histopathological features, and the prognostic implications of the observed inter- and intraobserver variation. Based on the observations, we have eliminated criteria with poor inter-/intraobserver agreement as well as those implying no or minimal impact on the prognosis. We propose a new simplified histopathological definition of medullary carcinoma of the breast (MC), retaining reproducible, prognostically significant criteria (syncytial growth pattern and diffuse, moderate or marked mononuclear infiltration). The prognosis of MC, based on this definition, is significantly better than those of infiltrating ductal carcinomas grade II + III.

Entities:  

Mesh:

Year:  1991        PMID: 2021545      PMCID: PMC1972345          DOI: 10.1038/bjc.1991.137

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.

Authors:  R L Ridolfi; P P Rosen; A Port; D Kinne; V Miké
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  [The kappa coefficient--a goal for evaluating the reproducibility of nominal and ordinary data].

Authors:  T Gjørup; A M Jensen
Journal:  Nord Med       Date:  1986

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Organisation of the Danish adjuvant trials in breast cancer.

Authors:  K W Andersen; H T Mouridsen; T Castberg; K Fischerman; J Andersen; K Hou-Jensen; H Brincker; H Johansen; E Henriksen; M Rørth; N Rossing
Journal:  Dan Med Bull       Date:  1981-08

5.  Quality control in histopathology and diagnostic cytology.

Authors:  F A Langley
Journal:  Histopathology       Date:  1978-01       Impact factor: 5.087

6.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

7.  Prognostic factors in cancer of the female breast. II. Reproducibility of histopathologic classification.

Authors:  S J Cutler; M M Black; G H Friedell; R A Vidone; I S Goldenberg
Journal:  Cancer       Date:  1966-01       Impact factor: 6.860

8.  Analysis of reproducibility of subjective grading systems for breast carcinoma.

Authors:  B Stenkvist; S Westman-Naeser; J Vegelius; J Holmquist; B Nordin; E Bengtsson; O Eriksson
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

9.  Intralaboratory variations in the grading of breast carcinoma.

Authors:  G S Delides; G Garas; G Georgouli; D Jiortziotis; J Lecca; T Liva; J Elemenoglou
Journal:  Arch Pathol Lab Med       Date:  1982-03       Impact factor: 5.534

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  8 in total

Review 1.  Human antibodies in cancer and autoimmune disease.

Authors:  H J Ditzel
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.

Authors:  J Huober; S Gelber; A Goldhirsch; A S Coates; G Viale; C Öhlschlegel; K N Price; R D Gelber; M M Regan; B Thürlimann
Journal:  Ann Oncol       Date:  2012-06-14       Impact factor: 32.976

3.  The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Authors:  M H Hansen; H Nielsen; H J Ditzel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 4.  Demystifying basal-like breast carcinomas.

Authors:  L Da Silva; C Clarke; S R Lakhani
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

5.  Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.

Authors:  S Holck; L Pedersen; T Schiødt; K Zedeler; H Mouridsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.

Authors:  Asude Aksoy; Hatice Odabas; Serap Kaya; Oktay Bozkurt; Mustafa Degirmenci; Turkan O Topcu; Aydin Aytekin; Erkan Arpaci; Nilufer Avci; Kezban N Pilanci; Havva Y Cinkir; Yakup Bozkaya; Yalcin Cirak; Mahmut Gumus
Journal:  Saudi Med J       Date:  2017-02       Impact factor: 1.484

8.  Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation.

Authors:  Manmeet Kaur; Kanwardeep Kaur Tiwana; Nisha Singla
Journal:  Niger J Surg       Date:  2019 Jan-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.